Global Humanized Mouse Model Market Strategies and Forecast Till, 2024-2032

Humanized Mouse Model Market Size And Forecast

Humanized Mouse Model Market size was valued at USD 95.72 Million in 2019 and is projected to reach USD 188.57 Million by 2027, growing at a CAGR of 9.54% from 2020 to 2027.

The key factors propelling the growth of the market are the increasing number of research activities involving humanized models, growing demand for personalized medicine, an increasing number of R&D activities in pharmaceutical and biotechnology companies, and continuous support in the form of investments and grants from the government and private sectors. The Global Humanized report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Humanized Mouse Model Market Definition

The humanized mouse is a mouse that possesses functioning human genes, cells, tissues, and/or organs in the case of biological and medical research for human therapeutics. These mouse models are used to model the human immune system in scenarios of health and pathology. Humanized mouse models are used for basic research, safety assessment for large molecule therapeutics, modeling of certain human-specific infectious diseases, and efficacy testing of immunotherapy approaches. The human protein is expressed while the mouse protein is suppressed in all cells and tissues. Humanized mouse models are important tools required to conduct preclinical research, mimic human pathological conditions, test compound efficacy, and measure its effects on human proteins.

The model requires accurate risk assessment and thorough analysis to preserve the physiological expression and regulation of the human gene inserted into the mouse genome. In order to determine the optimal expression and functionality of the human protein in a mouse environment, the genes and proteins of both, the mouse and human, are analyzed for accuracy and structure. Humanized mouse models are used in biomedical research including cancer biology, regenerative medicine, human hematopoiesis, infectious diseases, transplantation, and autoimmunity. They enable a better understanding of disease pathways and ultimately improve the translational value of preclinical studies.

Global Humanized Mouse Model Market Overview

This technology can be used to produce animal models with more humanized pathological conditions, including genetic disorders. This model can also be used to determine drug effectiveness and metabolism that have normal physiological environments such as human organ function and microbial flora. Since disease models reflecting human physiology faithfully can be produced and used for more accurate non-clinical study and drug discovery, high demand from researchers is expected.

Usage of mouse models for identification of immunodeficiency disorders, cancers, and other rare diseases, increase in R&D activities carried out by pharmaceutical & biotechnology companies; continuous support & initiatives from governments & private sectors for research on mouse models; and growth in adoption of modified medicine increase the demand for personalized mouse models. Technological advancements, the growing prevalence of cancer, research & development activities, and the rising adoption of personalized medicines are factors predicted to drive the global Humanized Mouse Model Market.

Government investment to plays a key role in motivating the market. However, stringent regulations and laws formulated for ethical use of animals and costly procedures for maintenance of animal housing restrain the growth of the global Humanized Mouse Model Market. Increased production of monoclonal antibodies and improvement of healthcare in developing nations are expected to provide growth opportunities for the market.

Global Humanized Mouse Model Market: Segmentation Analysis

The Global Humanized Mouse Model Market is Segmented on the basis of Type, Application, End-User, And Geography.

Humanized Mouse Model Market, By Type

• Genetic Humanized Mouse Model• Cell-Based Humanized Mouse Modelo CD34 Humanized Mouse Model (Hu-CD34)o PBMC Humanized Mouse Modelo BLT Humanized Mouse Model

Based on Type, the market is bifurcated into Genetic Humanized Mouse Model and Cell-Based Humanized Mouse Model. The genetic humanized mouse models segment accounted for the largest share of the market. The large share of this segment can be attributed to the wide use of genetic humanized mouse models in the analysis of compounds, biological efficacy and safety testing, the study of drug metabolism and disposition, and investigation of immune system development and function.

Humanized Mouse Model Market, By Application

• Immunology and Infectious Diseases• Neuroscience• Oncology• Haematopoiesis• Toxicology• Others

Based on Application, the market is bifurcated into Immunology and Infectious Diseases, Neuroscience, Oncology, Haematopoiesis, Toxicology, Others. The immunology segment had a fair share of the market in the past few years. The oncology segment is expected to witness the highest growth, owing to the rising number of cancer research activities and increasing innovation to develop humanized mouse models tailored to meet the specific needs of cancer research.

Humanized Mouse Model Market, By End-User

• Pharmaceutical & Biotechnology Companies• Contract Research Organizations• Academic & Research Institutions

Based on End-User, the market is bifurcated into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic & Research Institutions. The Contract Research Organizations segment is estimated to be the fastest-growing with a high CAGR during the forecast period. The growth in the number of pharmaceutical companies outsourcing their preclinical studies to Contract Research Organizations will bring about growth in the sector. Researchers and academicians worldwide are concentrating on the development of innovative vaccines and therapeutics employing humanized mice model, as the data collected from these models are helpful in predicting the clinical outcome of specific drugs in development. This is anticipated to trigger the demand for these models in the pharmaceutical industry, CROs as well as academic and research institutes, thus, benefitting the market in turn.

Humanized Mouse Model Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

Based on regional analysis, the global Humanized Mouse Model Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounts for a larger share of the global Humanized Mouse Model Market. This large share is attributed due to increased R&D spending by pharmaceutical companies and increasing biomedical research. Followed by which are Europe and the Asia Pacific. The Humanized Mouse Model Market is expected to witness a high growth rate in the Asia-Pacific and Latin America reasons being increasing investments from the private sector and government in the life sciences sector, research in regenerative medicines, increase in animal research, rising focus on personalized medicines, growth in translational and biomedical research, growth in the pharmaceutical industries, and rising pharmaceutical and biotechnology R&D activities in these regions.

Key Players

The “Global Humanized Mouse Model Market ” study report will provide valuable insight with an emphasis on the global market. The major players in the market are The Jackson Laboratory, Taconic Biosciences, Inc., Horizon Discovery Group PLC, Genoway S.A., Harbour Antibodies Bv (A Subsidiary of Harbour Biomed), Humurine Technologies, Vitalstar Biotechnology Co., Ltd., Ingenious Targeting Laboratory, Axenis S.A.S, Trans Genic, Inc., Champions Oncology, Inc., Crown Bioscience, Inc. 

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Partnerships, Collaborations, and Agreements

• 2021 Heligenics, Inc. has announced a new partnership with The Jackson Laboratory (JAX). This collaborative project will make the functional output of Variants of Unknown Significance (VUS) throughout a key portion of the ERBB2 gene available through the JAX Clinical Knowledgebase (CKB), a digital resource that connects clinicians and researchers from around the world to interpret complex cancers.

• 5th June 2018. LakePharma and Harbour Antibodies BV, a Harbour BioMed subsidiary, announced a technology partnership in which LakePharma will use Harbour Antibodies’ patented H2L2 transgenic mouse platform in its therapeutic antibody discovery service offerings to pharmaceutical and therapeutic biotechnology clients.

Mergers and Acquisitions

• January 2020 H.I.G. Capital announced that one of its affiliates has joined forces with the management team of Taconic Biosciences, Inc. (“Taconic” or the “Company”) to support the Company’s growth as a leading global provider of research models and services to the pharmaceutical, biotechnology, contract research organization (CRO), and academic research industries.

• December 2020. PerkinElmer, Inc. and Horizon Discovery Group plc announced an agreement on the terms of a recommended all-cash offer in which PerkinElmer will acquire Horizon for approximately $383 million (£296 million).

Product Launches and Product Expansions

• 13 January 2020 – Taconic Biosciences, a global leader in the development of drug discovery animal models, has opened a new model generation facility in Leverkusen, Germany. This location, which replaces the previous Taconic location in Cologne, Germany, houses model generation services.

• January 2021 Champions Oncology, Inc., a leading global oncology technology company that is transforming drug discovery and development through data-driven research strategies, announced today the expansion of its Lumin Bioinformatics SaaS program.

Report Scope

Top Trending Report:

Research Methodology of Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as a future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.